| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33a8b90e17647cb1cbf9a2b4c5f56429
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6c1c3443a1ffff774e889be9593dde78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_20b1ddb78bc3b5ceb1adfc62325fea79
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72bbf2ac62a36b3ba281f7a30995ebb1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff6e5d06aac7d7d14c6165bae5095c52 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-53 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-428 |
| filingDate |
2010-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7226e6835d4b6a1d5af3090ed5dc1fbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc1829ec5cd3a7148c315a9929976bfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9671777361fb04ef5df100be081ea4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c4bab596fcd295246d2791ee19a5591 |
| publicationDate |
2010-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2010147309-A2 |
| titleOfInvention |
Pharmaceutical composition for preventing or treating inflammatory gastrointestinal disease comprising patchouli extract |
| abstract |
The present invention provides a pharmaceutical composition for preventing or treating inflammatory gastrointestinal disease, and in particular a pharmaceutical composition for preventing or treating ulcerative colitis, Crohn's disease, irritable bowel syndrome or gastritis, which comprises patchouli ( Pogostemon cablin ) extract as an active ingredient. The patchouli extract has a prophylactic and therapeutic action against ulcerative colitis or Crohn's disease which are commonly known as inflammatory bowel disease, as it effectively suppresses inflammatory bowel disease induced by trinitrobenzene sulfonic acid (TNBS) and also reduces MPO (myeloperoxidase) activity. Further, the patchouli extract not only has a prophylactic and therapeutic action against irritable bowel syndrome because it suppresses contraction of small-intestine and large-intestine circular muscle, but it also has a prophylactic and therapeutic action against gastritis because it has a protective action (cytoprotective action) in damaged gastric mucosa. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108379365-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106511323-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110151739-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108379365-B |
| priorityDate |
2009-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |